Urology
Volume 68, Issue 2, Supplement , Pages 29-37, August 2006

Patient-reported outcomes in overactive bladder: The influence of perception of condition and expectation for treatment benefit

  • Daniela Marschall-Kehrel

      Affiliations

    • Urological Consultancy, Oberursel, Germany
    • Corresponding Author InformationReprint requests: Daniela Marschall-Kehrel, MD, Urological Office, Urological Consultancy, Vorstadt 20, 61440 Oberursel, Germany.
    • Daniela Marschall-Kehrel is on the pediatric advisory board of Novartis; and is a member of ATLAS (Novartis) and NEXUS (Pfizer Inc).
    • ,
  • Richard G. Roberts

      Affiliations

    • Department of Family Medicine, University of Wisconsin Medical School, Madison, Wisconsin, USA
    • Richard Roberts is a consultant for Astellas, Novartis, and Pfizer Inc; and an investigator for Pfizer Inc.
    • ,
  • Linda Brubaker

      Affiliations

    • Departments of Obstetrics, Gynecology, and Urology, Loyola University Medical Center, Maywood, Illinois, USA
    • Linda Brubaker receives research funding from Q-Med, Pfizer Inc, and Allergan Inc. and receives consultant/speaker honoraria from Q-Med, Novartis, Pfizer Inc, and Astellas.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0090-4295(06)00774-6

doi:10.1016/j.urology.2006.02.046

Urology
Volume 68, Issue 2, Supplement , Pages 29-37, August 2006

Article Tools

* Image Usage & Resolution